A global, secure, online, de-identified, Personal Health Identifier-free registry to record all COVID-19+ #atopicdermatitis patients on immunomodulating therapy
Does receiving a #COVID19 vaccine affect people with eczema? Does it cause eczema to flare? We are asking all patients with #eczema to complete the SECURE-AD patient #survey to tell us how the pandemic, including COVID vaccines, affects those with eczema https://t.co/qevYG5HMDd
Many more have received their #COVID19 vaccine(s). But does it affect people with #eczema? And how? We are asking patients with #eczema worldwide to complete the SECURE-AD patient #survey to let us know how the pandemic, including vaccines, affected them. https://t.co/XGgXn8HAPE
Do you have #eczema and have you already had #COVID19#vaccine? Or maybe you have eczema and you're worried about vaccine side effects ? Please fill in our survey and help us find out how #vaccines affect people with eczema https://t.co/Jwyao5bZcg
Does receiving a #COVID19 vaccine affect people with #eczema? @ad_secure is asking all patients with #eczema to complete the patient #survey. They investigate how the pandemic, including COVID vaccines, affects those with #eczema. See https://t.co/pbmMmJBI4J. Thanks!
Does receiving a #COVID19 vaccine affect people with eczema? Does it cause eczema to flare? We are asking all patients with #eczema to complete the SECURE-AD patient #survey to tell us how the pandemic, including COVID vaccines, affects those with eczema https://t.co/qevYG5HMDd
The @ad_secure team is asking everyone with atopic #eczema to complete their survey, which will provide insights into how the pandemic affected the eczema community & how Covid-19 vaccinations may affect people with eczema. 💉
More info here👉https://t.co/6MY9ln0odI. Thank you!
Patients from around the world can report their own experience of #COVID19 at the SECURE-AD Patient Survey. We are about to launch a new survey regarding #COVID19#Vaccinations in patients with #eczema/#atopicdematitis Stay tuned!
The first SECURE-AD results are being prepared for publication 🖥️📈📊 Huge thanks to all contributors. Any Dr/Nurse registering a case will be included in the publication! Patients with #eczema who had #COVID19 at any time should be registered anonymously https://t.co/9lQ69QUyrL
Remember that cases of #COVID19 at any time in the past can be recorded. As you see #atopicdermatitis#eczema patients for their regular eczema care, please ask about any previous #COVID infection and report their cases in the #SECURE_AD registry. #Retweet and share please!
An excellent piece on #COVID19 and #eczema on VerywellHealth. It covers how covid may influence eczema severity and what to to, about health care in covid times and also mentions our SECURE-AD registry (https://t.co/XGgXn8HAPE). Visit: https://t.co/C9z1Fi0W7M for the article.
Very grateful for the physicians reporting to the #AtopicDermatitis and #COVID19 registry. Below our latest results of 241 cases. Visit https://t.co/Qfonk1ZMyr to see more. Do you have #AtopicDermatitis and had #COVID19? Ask your doctor to report your case https://t.co/JdaEDDyRJd
Thanks to +500 people with #AtopicDermatitis (#eczema) who completed the SECURE-AD Patient Survey. The graph shows what happened to almost 200 of those who actually had #COVID19. If you have #AtopicDermatitis and had #COVID19, please complete our survey on https://t.co/XGgXn8HAPE
Prof Phyllis Spuls, dermatologist/study lead SECURE-AD, draws your attention to her upcoming talk about the “Use of Biologics and Immunosuppressive Drugs during the COVID-19 Pandemic” at the @eadv congress. If you have eczema and had #COVID19 please visit https://t.co/Qfonk1ZMyr.
Great work by our @PsoProtect friends. Real-world #patientregistry data is always vital, but particularly during #COVID19. Please support
https://t.co/9ZFBHqlKk2
@ad_secure@SecureAa https://t.co/yHfmmMZ6wu
https://t.co/IG0hDthTcm
https://t.co/xJeLrElETe
Exciting results showing effects of new systemic and biologic drugs against dupilumab in #atopicdermatitis. How do they compare in the context of #COVID19? More patients and physicians registering cases will help answer this important question #dermtwitter#eczema#dermresearch
Here is a forest plot with some highlights: results for change in EASI score vs. dupilumab for some investigational medications we have newer data for (abrocitinib, baricitinib, lebrikizumab) in adults with atopic dermatitis. 1/2
How does #COVID19 affect people with #eczema? Help
@ad_secure to find that out. Do you have #eczema? Had #COVID19? Please fill in the patient survey at https://t.co/Hva9smsa2K. Our patient representative Tim explains the project in a short video.
@eczemaresearch@2pm Hi, sorry we missed this - but! we will be uploading the presentation to youtube. Will tag you when it's available - feel free to spread to your members :)
The first results from SECURE-AD Registry results will be presented at the ISAD Virtual meeting TODAY @2pm (UK time). Find out if having eczema, or if treatments for eczema affect the outcomes of COVID-19.
Register here: https://t.co/tM47T5XI8T
#dermtwitter#COVID19#eczema
Join us to hear the first results of SECURE-AD Registry presented at the ISAD meeting - starting in 5 minutes. Register to submit questions or watch on YouTube:
https://t.co/Bi9Naqhe8K
#dermtwitter#COVID19#eczema